Showing results (11-20 of 201) with videos related to
Sort By:
Pageof 21
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 9, 2000
[Dyslipidemia in insulin resistance and its improvement by troglitazone]K Yagi, H MabuchiCurrent Opinion in Lipidology|November 11, 1999
Therapeutic effects of LDL apheresis in the prevention of atherosclerosisK Kajinami, H MabuchiClinical Chemistry|April 1, 1983
Liquid-chromatographic profiling of endogenous fluorescent substances in sera and urine of uremic and normal subjectsH Mabuchi, H NakahashiTherapeutic Drug Monitoring|January 1, 1988
Displacement by anionic drugs of endogenous ligands bound to albumin in uremic serumH Mabuchi, H NakahashiNephron|January 1, 1983
Medium-sized peptides in the blood of patients with uremiaH Mabuchi, H NakahashiJournal of Chromatography|December 10, 1982
Profiling of urinary medium-sized peptides in normal and uremic urine by high-performance liquid chromatographyH Mabuchi, H NakahashiNephron|January 1, 1988
A major endogenous ligand substance involved in renal failureH Mabuchi, H NakahashiNephron|January 1, 1988
Inhibition of hepatic glutathione S-transferases by a major endogenous ligand substance present in uremic serumH Mabuchi, H NakahashiNephron|January 1, 1988
A major inhibitor of phenytoin binding to serum protein in uremiaH Mabuchi, H NakahashiNephron|January 1, 1986
Isolation and characterization of an endogenous drug-binding inhibitor present in uremic serumH Mabuchi, H NakahashiPageof 21